The Modulation of CD40 Ligand Signaling by Transmembrane CD28 Splice Variant in Human T Cells

Sebastian A. Mikolajczak, Bruce Y. Ma, Tetsuya Yoshida, Ryoko Yoshida, David J. Kelvin, Atsuo Ochi

Research output: Contribution to journalArticlepeer-review

17 Citations (Scopus)

Abstract

The role of CD40 ligand (CD40L)/CD40 signaling in T cell-dependent B cell differentiation and maturation has been amply documented. The mechanism of CD40 signaling in B cells has been well established, whereas the signaling mechanism of CD40L in T cell costimulation remains unknown. In this study we show that CD28i, a transmembrane splice variant of CD28 costimulatory receptor, complexes with CD40L in human T cells. The cross-linking of CD40L resulted in the coendocytosis of CD28i with CD40L. The tyrosine phosphorylation of CD28i followed the cross-linking of CD40L, and the overexpression of CD28i augmented the c-Jun NH2-terminal kinase, p21-activated kinase 2, and nuclear factor βB activation. These data indicate that CD28i, by functioning as a signaling adaptor, transduces CD40L signaling as well as CD28 signaling in human T cells.

Original languageEnglish
Pages (from-to)1025-1031
Number of pages7
JournalJournal of Experimental Medicine
Volume199
Issue number7
DOIs
Publication statusPublished - Apr 5 2004

ASJC Scopus Subject Areas

  • General Medicine

PubMed: MeSH publication types

  • Journal Article
  • Research Support, Non-U.S. Gov't

Fingerprint

Dive into the research topics of 'The Modulation of CD40 Ligand Signaling by Transmembrane CD28 Splice Variant in Human T Cells'. Together they form a unique fingerprint.

Cite this